959
S. P. Chavan et al.
Paper
Synthesis
IR (CHCl3): 3081, 1970, 1644, 1614, 1512, 1247, 755 cm–1
.
13C NMR (50 MHz, CDCl3 + CCl4): δ = 20.6, 28.1, 49.5, 83.2, 110.1,
128.1, 131.3, 141.0, 153.2, 168.25.
MS (ESI): m/z = 226 (M + H)+.
1H NMR (200 MHz, CDCl3 + CCl4): δ = 1.08 (t, J = 7.5 Hz, 3 H), 1.65 (s, 3
H), 2.33 (q, J = 7.5 Hz, 2 H), 3.77–3.87 (m, 5 H), 4.51 (s, 2 H), 4.67–4.95
(m, 2 H), 5.10 (s, 2 H), 6.82 (d, J = 8.5 Hz, 2 H), 7.17 (d, J = 8.5 Hz, 2 H).
13C NMR (50 MHz, CDCl3 + CCl4): δ = 11.4, 19.65, 26.9, 45.2, 47.6, 49.8,
52.3, 54.6, 111.9, 112.2, 113.3, 113.6, 127.9, 129.1, 139.9, 146.0,
158.65, 172.3 (mixture of rotamers).
3-Ethyl-1-(4-methoxybenzyl)-4-methyl-1,5-dihydro-2H-pyrrol-2-
one (10d); Typical Procedure
To a degassed homogeneous solution of 13d (0.2 g, 0.7 mmol) in an-
hyd toluene (20 mL), Grubbs’ 2nd generation catalyst (0.062 g, 10
mol%) and Ti(Oi-Pr)4 (2 equiv) were added under an argon atmo-
sphere; the resultant mixture was heated at 80 °C for 12 h. When the
reaction was complete (TLC), the solvent was removed on a rotary
evaporator under reduced pressure and residue obtained was purified
by flash column chromatography (silica gel, EtOAc–petroleum ether,
1:4) to provide lactam 10d (0.072 g, 40%) as a yellow solid and 0.11 g
of starting material was recovered; mp 127–131 °C.
MS (ESI): m/z = 274 (M + H)+.
Anal. Calcd for C17H23NO: C, 74.69; H, 8.48; N, 5.12. Found: C, 74.63;
H, 8.37; N, 5.23.
N-(4-Methoxybenzyl)-N-(2-methylallyl)acrylamide (13b)
Yield: 205 mg (80%); colorless liquid.
IR (CHCl3): 2935, 1646, 1612, 1512 cm–1
.
IR (CHCl3): 1671, 1515, 1248, 1212, 757 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 1.62–1.79 (m, 3 H), 3.64–4.11 (m, 5 H),
4.43–4.65 (m, 2 H), 4.71–5.05 (m, 2 H), 5.61–5.78 (m, 1 H), 6.33–6.70
(m, 2 H), 6.76–6.96 (m, 2 H), 7.03–7.25 (m, 2 H).
13C NMR (100 MHz, CDCl3): δ = 20.1, 48.0 (49.0), 50.5, (51.8), 55.2,
111.7 (112.4), 113.8 (114.2), 127.6, 127.7, 128.3 (128.5), 128.8, 129.5,
129.7, 139.8 (140.4), 158.9 (159.0), 166.7 (166.9).
1H NMR (200 MHz, CDCl3 + CCl4): δ = 1.07 (t, J = 7.6 Hz, 3 H), 1.91 (s, 3
H), 2.28 (q, J = 7.6 Hz, 2 H), 3.56 (s, 2 H), 3.77 (s, 3 H), 4.51 (s, 2 H), 6.82
(d, J = 8.8 Hz, 2 H), 7.14 (d, J = 8.8 Hz, 2 H).
13C NMR (50 MHz, CDCl3 + CCl4): δ = 12.9, 12.95, 18.9, 46.1, 53.2, 54.3,
113.8, 128.1, 128.6, 135.0, 144.95, 158.7, 171.7.
HRMS (ESI+): m/z calcd for C15H19NO2 [M + H]+: 246.1494; found:
MS (ESI): m/z = 246 (M + H)+, 268 (M + Na)+.
246.1498.
Anal. Calcd for C15H19NO: C, 73.44; H, 7.81; N, 5.71. Found: C, 73.47;
H, 7.78; N, 5.76.
N-(4-Methoxybenzyl)-N-(2-methylallyl)methacrylamide (13c)
Yield: 200 mg (73%); colorless liquid.
IR (CHCl3): 2930, 1648, 1614, 1465 cm–1
1-(4-Methoxybenzyl)-3,4-dimethyl-1H-pyrrol-2(5H)-one (10c)
.
Yield: 39 mg (44%); pale yellowish liquid.
1H NMR (400 MHz, CDCl3): δ = 1.54–1.76 (m, 3 H), 1.98 (br s, 3 H),
3.66–4.02 (m, 5 H), 4.40–4.59 (m, 2 H), 4.63–5.02 (m, 2 H), 5.04–5.34
(m, 2 H), 6.85–6.89 (m, 2 H), 6.99–7.25 (m, 2 H).
13C NMR (100 MHz, CDCl3): δ = 19.9, 20.6 (20.8), 45.6 (48.0), 50.1
(52.8), 55.1, 112.4, 113.9, 114.7, 114.9, 128.1, 128.5, 129.2 129.5,
139.9 (140.2), 140.5 (140.7), 158.9, 173.0.
IR (CHCl3): 2940, 1666, 1513, 1460 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 1.84 (s, 3 H), 1.92 (s, 3 H), 3.61 (s, 2 H),
3.81 (s, 3 H), 4.56 (s, 2 H), 6.86 (d, J = 8.80 Hz, 2 H), 7.19 (d, J = 8.56 Hz,
2 H).
13C NMR (100 MHz, CDCl3): δ = 8.7, 12.9, 45.4, 53.5, 55.2, 114.0, 128.6,
129.3, 129.8, 145.7, 158.9, 172.6.
HRMS (ESI+): m/z calcd for C16H21NO2 [M + H]+: 260.1650; found:
260.1650.
HRMS (ESI+): m/z calcd for C14H17NO2 [M + H]+: 232.1337; found:
232.1337.
N-Benzyl-N-(2-methylallyl)-2-methylenebutanamide (13f)
1-Benzyl-3-ethyl-4-methyl-1H-pyrrol-2(5H)-one (10f)
Yield: 303 mg (67%); colorless liquid.
Yield: 38 mg (43%); colorless viscous liquid.
IR (CHCl3): 3020, 1648, 1617, 1421 cm–1
.
IR (CHCl3): 2925, 1671, 1656, 1458 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 1.03–1.21 (m, 3 H), 1.58–1.80 (m, 3 H),
2.26–2.46 (m, 2 H), 3.69–4.07 (m, 2 H), 4.48–4.67 (m, 2 H), 4.67–5.06
(m, 2 H), 5.14 (s, 2 H), 7.06–7.44 (m, 5 H).
13C NMR (100 MHz, CDCl3): δ = 11.6, 20.0, 27.1, 46.3 (48.3), 50.7
(52.9), 112.5, 124.5, 126.8, 127.3 (127.4), 128.2, 128.5, 128.7, 136.7
(137.2), 139.9 (140.2), 146.1 (146.3), 173.2.
1H NMR (400 MHz, CDCl3): δ = 1.12 (t, J = 7.5 Hz, 3 H), 1.95 (s, 3 H),
2.34 (q, J = 7.5 Hz, 2 H), 3.63 (s, 2 H), 4.64 (s, 2 H), 7.21–7.42 (m, 5 H).
13C NMR (100 MHz, CDCl3): δ = 12.8, 13.1, 17.0, 46.0, 53.6, 127.3,
128.0, 128.6, 134.2, 137.7, 145.4, 172.2.
HRMS (ESI+): m/z calcd for C14H17NO [M + H]+: 216.1388; found:
216.1390.
HRMS (ESI+): m/z calcd for C16H21NO [M + H]+: 244.1701; found:
244.1699.
tert-Butyl 4-Methyl-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxylate
(10g)6e,h
tert-Butyl Acryloyl(2-methylallyl)carbamate (13g)
Yield: 28 mg (37%); thick colorless oil.
Yield: 320 mg (59%); thick colorless oil.
IR (CHCl3): 3364, 2979, 2937, 1734, 1687, 1619, 1404 cm–1
1H NMR (200 MHz, CDCl3 + CCl4): δ = 1.48 (s, 9 H), 1.72 (s, 3 H ), 4.23
(s, 3 H), 4.67–4.80 (2 s, 2 H), 5.69 (dd, J = 10.4, 1.9 Hz, 1 H), 6.32 (dd,
J = 16.8, 1.9 Hz, 1 H), 7.04 (dd, J = 16.8, 10.4 Hz, 1 H).
IR (CHCl3): 3448, 2980, 1778, 1739, 1712, 1643, 1447, 1293, 1164,
.
843, 755 cm–1
.
1H NMR (200 MHz, CDCl3 + CCl4): δ = 1.52 (s, 9 H), 2.07 (s, 3 H), 4.17 (s,
2 H), 5.80 (s, 1 H).
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2015, 47, 955–960